Contour® Next One

The CONTOUR ® NEXT ONE smart meter and app system combines remarkable accuracy with ease-of- use to benefit a broad range of patients living with diabetes. 92% of users think it is quicker and easier to interpret readings using the CONTOUR ® NEXT ONE smartLIGHT feature* *

Display: LCD with backlight
Dimensions: 3.82″; x 1.12″; x 0.6″
Weight: 1.27 oz
Battery Type: 2 3-volt coin-cell batteries (CR2032)
Battery Life: Approximately 1000 tests (1 yr. average use/ 3 tests per day)
Sample size: 0.6 μL

Measuring Range: 20 mg/dL–600 mg/dL of glucose in blood
Memory capacity: up to 800 blood glucose results
Test averages: 7, 14, 30, 90 days
Result Time: 5 seconds
Data transfer: Infrared (IR) window
Compatible Test Strip: Contour® Next Test Strips
Compatible Lancing Device: Microlet Next
Optional Control Solution: Contour® Next Control Solution
– No Coding
– CONTOUR®NEXT ONE is our most accurate meter yet, shown to deliver remarkable accuracy within
±8.4% of lab values**
– smartLIGHT target range indicator immediately identifies if blood glucose readings are above, below or
within target range, giving patients instant feedback
– Second-Chance® sampling allows your patients up to 60 seconds to reapply more blood which may help
prevent wasted strips while still demonstrating a high degree of accuracy*
– New age of smart diabetes management
– Seamlessly connect via Bluetooth® technology
– Contour® Diabetes app available for download

* The SMARTSON user test evaluation of the CONTOUR® NEXT ONE meter and the CONTOUR® DIABETES app, June 2017, Sweden.

* 8.4% applies to values ≥ 100mg/dL. An Ad hoc analysis demonstrated that 95% of results fell within ±8.4 mg/dL or ±8.4% of the laboratory reference values for glucose concentrations & 100 mg/dL or ≥100 mg/dL, respectively, when tested via subject–obtained capillary fingertip results (patients).1

* Harrison, B. et al. Performance and Accuracy Capability of a New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device: Laboratory and Clinical Sample Reapplication Studies. Poster presented at the 10th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD); February 15-18, 2017; Paris, France.

There are no reviews yet.

Be the first to review “Contour® Next One”